Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
XTL Biopharmaceuticals Ltd. (IL:XTLB)
:XTLB
XTLB Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.00 - 17.10
Previous CloseN/A
Volume3.12M
Average Volume (3M)N/A
Market Cap
68.99M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.08
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,254,343,300
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
XTLB FAQ
What was XTL Biopharmaceuticals Ltd.’s price range in the past 12 months?
XTL Biopharmaceuticals Ltd. lowest stock price was 0.00 and its highest was 17.10 in the past 12 months.
What is XTL Biopharmaceuticals Ltd.’s market cap?
XTL Biopharmaceuticals Ltd.’s market cap is 68.99M.
When is XTL Biopharmaceuticals Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were XTL Biopharmaceuticals Ltd.’s earnings last quarter?
XTL Biopharmaceuticals Ltd. released its earnings results on May 31, 2023. The company reported -0.6 earnings per share for the quarter, missing the consensus estimate of N/A by -0.6.
Is XTL Biopharmaceuticals Ltd. overvalued?
According to Wall Street analysts XTL Biopharmaceuticals Ltd.’s price is currently Overvalued.
Does XTL Biopharmaceuticals Ltd. pay dividends?
XTL Biopharmaceuticals Ltd. does not currently pay dividends.
What is XTL Biopharmaceuticals Ltd.’s EPS estimate?
XTL Biopharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does XTL Biopharmaceuticals Ltd. have?
XTL Biopharmaceuticals Ltd. has 1,254,343,300 shares outstanding.
What happened to XTL Biopharmaceuticals Ltd.’s price movement after its last earnings report?
XTL Biopharmaceuticals Ltd. reported an EPS of -0.6 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.878%.
Which hedge fund is a major shareholder of XTL Biopharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IL:XTLB
---
Technical Analysis
---